FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment

Author： Smerieri Arianna Montanini Luisa Maiuri Luigi Bernasconi Sergio Street Maria E.

Publisher： MDPI

E-ISSN： 1422-0067|15|10|18000-18022

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.15, Iss.10, 2014-10, pp. : 18000-18022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation

By Ribeiro Carla M. P. Lubamba Bob A.

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 118-118

MDPI

Access to resources Recommend Favorite

Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis

By Ideozu Justin E. Zhang Xi Pan Amy Ashrafi Zainub Woods Katherine J. Hessner Martin J. Simpson Pippa Levy Hara

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1752-1752

MDPI

Access to resources Recommend Favorite

Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches

By Kłodzińska Sylvia Natalie Priemel Petra Alexandra Rades Thomas Mørck Nielsen Hanne

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-10 ,pp. : 1688-1688

MDPI

Access to resources Recommend Favorite

High-Dose Ibuprofen in Cystic Fibrosis

By Lands Larry C. Dauletbaev Nurlan

Pharmaceuticals, Vol. 3, Iss. 7, 2010-07 ,pp. : 2213-2224

MDPI

Access to resources Recommend Favorite

Determinants of Serum Glycerophospholipid Fatty Acids in Cystic Fibrosis

By Drzymała-Czyż Sławomira Krzyżanowska Patrycja Koletzko Berthold Nowak Jan Miśkiewicz-Chotnicka Anna Moczko Jerzy A. Lisowska Aleksandra Walkowiak Jarosław

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 185-185

MDPI

Access to resources Recommend Favorite